The Affiliated Hospital Of Hangzhou Normal University
Clinical trials sponsored by The Affiliated Hospital Of Hangzhou Normal University, explained in plain language.
-
Zapping the brain to heal the liver: new trial tests TMS for fatty liver
Disease control Not yet recruitingThis study tests whether a non-invasive brain stimulation technique called rTMS can reduce liver fat in people with alcohol-related fatty liver disease (MetALD). 105 participants will receive either personalized rTMS, standard rTMS, or a sham (placebo) treatment over 20 sessions.…
Phase: NA • Sponsor: The Affiliated Hospital of Hangzhou Normal University • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC
-
Could aging clues in the blood predict heart attack recovery?
Knowledge-focused Not yet recruitingThis study follows 600 older adults (age 60+) who have had a heart attack to see if aging-related markers in their blood and body can predict future heart problems or death. Researchers collect medical data, blood samples, and heart scans over at least two years. The goal is to b…
Sponsor: The Affiliated Hospital of Hangzhou Normal University • Aim: Knowledge-focused
Last updated Jul 17, 2026 00:00 UTC
-
Fatty liver may be a hidden driver of heart attacks in diabetes
Knowledge-focused Not yet recruitingThis study follows 7,000 adults with type 2 diabetes and a common form of fatty liver disease (MASLD) to see how liver problems influence the risk of heart attacks, strokes, and heart failure. Researchers will track participants for five years, using advanced models to separate t…
Sponsor: The Affiliated Hospital of Hangzhou Normal University • Aim: Knowledge-focused
Last updated Jul 17, 2026 00:00 UTC